Taiwan Pavilion to Spotlight Innovation at Medicall Chennai 2023

TradeWinds announces the participation of Leltek and ACRO Biomedical in the Taiwan Pavilion at Medicall Chennai from August 2 to 4. Leltek will showcase its handheld ultrasound devices with innovative features, while ACRO Biomedical will launch its ABCcolla® Ophthalmic Matrix for corneal ulcers. Both companies emphasize their commitment to medical advancements.

TradeWinds has announced that Leltek and ACRO Biomedical will participate in the Taiwan Pavilion at the upcoming Medicall Chennai - Medical Equipment Exhibition & Conference, scheduled from August 2 to 4.

This development is significant for the medical technology sector. Attendees are encouraged to explore these advancements at booths #2C25E and #2C25F.

Leltek, renowned for its handheld ultrasound devices, boasts FDA 510k and CE certifications and earned the esteemed Taiwan Excellence Award in 2021. This recognition underscores the company's commitment to innovation and quality. The medical field is witnessing a shift towards portable ultrasound solutions, enabling quicker disease diagnosis and enhancing overall medical efficiency. Leltek's latest LK128 series features lightweight, waterproof designs with exceptional imaging capabilities.

ACRO Biomedical, a leader in natural collagen scaffold biomaterials, will launch its groundbreaking product, ABCcolla® Ophthalmic Matrix, in India. Having successfully completed clinical trials in Taiwan, the product is now undergoing extensive testing in India to treat corneal ulcers. Dr. Dar-Jen Hsieh, Chairman/CEO of ACRO Biomedical, expressed enthusiasm about this advancement. For further information or to schedule meetings during Medicall Chennai, attendees are invited to reach Leltek at info@leltek.com and ACRO Biomedical at niwang@acrobiomedical.com.

Attendees of Medicall Chennai can expect firsthand experiences with these technologies poised to revolutionize healthcare.

TradeWinds is a premier partner dedicated to advancing B2B marketing and sales development in the MedTech industry, aiming to shape the future of medical technology and improve healthcare outcomes worldwide.